Related references
Note: Only part of the references are listed.Regimented Phosphodiesterase Type 5 Inhibitor Use Reduces Emergency Department Visits for Recurrent Ischemic Priapism
Laurence T. Hou et al.
JOURNAL OF UROLOGY (2021)
Inflatable penile prosthesis implantation into scarred corporal bodies: timing may decrease postoperative problems
Kristi L. Hebert et al.
BJU INTERNATIONAL (2020)
Dutasteride in the long-term management of stuttering priapism
Ryan C. Baker et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2020)
Mechanisms underlying priapism in sickle cell disease: targeting and key innovations on the preclinical landscape
Biljana Musicki et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Management of Priapism: A Contemporary Review
Kirtishri Mishra et al.
SEXUAL MEDICINE REVIEWS (2020)
A Systematic Literature Review of the Burden of Ischemic Priapism in Patients with Sickle Cell Disease
Dave Nellesen et al.
BLOOD (2019)
PF-04447943, a Phosphodiesterase 9A Inhibitor, in Stable Sickle Cell Disease Patients: A Phase Ib Randomized, Placebo-Controlled Study
Robert J. Charnigo et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2019)
Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis
B. Musicki et al.
ANDROLOGY (2018)
Daily tadalafil for the chronic phase of stuttering priapism: a case report
Paolo Massenio et al.
BMC UROLOGY (2018)
The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
Eric H. Kim et al.
ASIAN JOURNAL OF UROLOGY (2018)
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
K. I. Ataga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Daily use of phosphodiesterase type 5 inhibitors as prevention for recurrent priapism
Archimedes Nardozza Junior et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2017)
Contemporary best practice in the evaluation and management of stuttering priapism
Georgios Kousournas et al.
THERAPEUTIC ADVANCES IN UROLOGY (2017)
Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 Dysregulation
Nikolai A. Sopko et al.
JOURNAL OF SEXUAL MEDICINE (2015)
Erectile Dysfunction after Sickle Cell Disease-Associated Recurrent Ischemic Priapism: Profile and Risk Factors
Uzoma A. Anele et al.
JOURNAL OF SEXUAL MEDICINE (2015)
Priapism Impact Profile Questionnaire: Development and Initial Validation
Arthur L. Burnett et al.
UROLOGY (2015)
Testosterone Replacement Therapy in Adolescents With Sickle Cell Disease Reverses Hypogonadism Without Promoting Priapism: A Case Report
Belinda F. Morrison et al.
UROLOGY CASE REPORTS (2015)
Randomized Controlled Trial of Sildenafil for Preventing Recurrent Ischemic Priapism in Sickle Cell Disease
Arthur L. Burnett et al.
AMERICAN JOURNAL OF MEDICINE (2014)
European Association of Urology Guidelines on Priapism
Andrea Salonia et al.
EUROPEAN UROLOGY (2014)
Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature
Uzoma A. Anele et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2014)
Prevention of Recurrent Ischemic Priapism with Ketoconazole: Evolution of a Treatment Protocol and Patient Outcomes
Michael P. Hoeh et al.
JOURNAL OF SEXUAL MEDICINE (2014)
Management of priapism: an update for clinicians
Helen R. Levey et al.
THERAPEUTIC ADVANCES IN UROLOGY (2014)
Standard Operating Procedures for Priapism
Arthur L. Burnett et al.
JOURNAL OF SEXUAL MEDICINE (2013)
Testosterone Replacement with 1% Testosterone Gel and Priapism: No Definite Risk Relationship
Arthur L. Burnett et al.
JOURNAL OF SEXUAL MEDICINE (2013)
Corporal Burnett Snake Surgical Maneuver for the Treatment of Ischemic Priapism: Long-Term Followup
Robert L. Segal et al.
JOURNAL OF UROLOGY (2013)
Sildenafil Citrate-Restored eNOS and PDE5 Regulation in Sickle Cell Mouse Penis Prevents Priapism Via Control of Oxidative/Nitrosative Stress
Trinity J. Bivalacqua et al.
PLOS ONE (2013)
Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report
B. F. Morrison et al.
ANDROLOGY (2013)
Androgen deprivation therapy before radical prostatectomy is associated with poorer postoperative erectile function outcomes
Clarisse R. Mazzola et al.
BJU INTERNATIONAL (2012)
Stuttering Priapism: Insights into Pathogenesis and Management
Belinda F. Morrison et al.
CURRENT UROLOGY REPORTS (2012)
A Prospective Diary Study of Stuttering Priapism in Adolescents and Young Men With Sickle Cell Anemia: Report of an International Randomized Control Trial-The Priapism in Sickle Cell Study
Ade B. Olujohungbe et al.
JOURNAL OF ANDROLOGY (2011)
Endothelial regulation of eNOS, PAI-1 and t-PA by testosterone and dihydrotestosterone in vitro and in vivo
L. Goglia et al.
MOLECULAR HUMAN REPRODUCTION (2010)
Corporal Snake Maneuver: Corporoglanular Shunt Surgical Modification for Ischemic Priapism
Arthur L. Burnett et al.
JOURNAL OF SEXUAL MEDICINE (2009)
Ketoconazole and Prednisone to Prevent Recurrent Ischemic Priapism
Michael R. Abern et al.
JOURNAL OF UROLOGY (2009)
Favorable Response to Intrathecal, But Not Oral, Baclofen of Priapism in a Patient With Spinal Cord Injury
Giangaetano D'Aleo et al.
SPINE (2009)
Treatment of Recurrent Priapism in Sickle Cell Anemia With Finasteride: A New Approach
Daibes Rachid-Filho et al.
UROLOGY (2009)
Sickle cell disease status and outcomes of African-American men presenting with priapism
Nelson Bennett et al.
JOURNAL OF SEXUAL MEDICINE (2008)
Priapism: Current principles and practice
Arthur L. Burnett et al.
UROLOGIC CLINICS OF NORTH AMERICA (2007)
Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism
Arthur L. Burnett et al.
JOURNAL OF SEXUAL MEDICINE (2006)
Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism
AL Burnett et al.
UROLOGY (2006)
Sickle cell disease and nitric oxide: A paradigm shift?
A. Kyle Mack et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Phosphodiesterase 5 mechanisms and therapeutic applications
AL Burnett
AMERICAN JOURNAL OF CARDIOLOGY (2005)
The physiological role of androgens in penile erection: Regulation of corpus cavernosum structure and function
A Traish et al.
JOURNAL OF SEXUAL MEDICINE (2005)
Long-term effects of finasteride on prostate specific antigen levels: Results from the Prostate Cancer Prevention Trial
RD Etzioni et al.
JOURNAL OF UROLOGY (2005)
Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism
HC Champion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The nitric oxide signaling pathway in the penis
AL Burnett et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Management of recurrent priapism in a cervical spinal cord injury patient with oral baclofen therapy
S Vaidyanathan et al.
SPINAL CORD (2004)
Follow-up of sickle cell disease patients with priapism treated by hydroxyurea
STO Saad et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Oral terbutaline in the management of pharmacologically induced prolonged erection
S Priyadarshi
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2004)
Priapism pathophysiology: clues to prevention
AL Burnett
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2003)
Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study
AB Adeyoju et al.
BJU INTERNATIONAL (2002)
Etilefrine for the prevention of priapism in adult sickle cell disease
I Okpala et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
P-selectin mediates the adhesion of sickle erythrocytes to the endothelium
NM Matsui et al.
BLOOD (2001)
Incidence of priapism in the general population
IA Eland et al.
UROLOGY (2001)
Share Paper
